TickerFacts.

Bioharvest Sciences Inc. (BHST): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.35M
Year ended 2025-12-31
$2.83M2023-12-31: $1.47M2024-12-31: $2.83M2025-12-31: $2.35M$2.35M
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.35M-16.9%2026-03-31, From 2025-01-01
2024-12-31$2.83M+92.3%2026-03-31, From 2024-01-01
2023-12-31$1.47Mn/a2025-03-31, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31$2.35M-16.9%
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31$0-100.0%
Earth Science Tech, Inc. (ETST)2026-03-31$756.6K+0.5%
Sunshine Biopharma Inc. (SBFM)2025-12-31$174.5K-89.5%
Lftd Partners Inc. (LIFD)2025-12-31$121.6K-61.2%
Zomedica Corp. (ZOMDF)2025-12-31$567.0K-89.1%
BGM Group Ltd. (BGM)2025-09-30$1.57M+552.4%
Verastem, Inc. (VSTM)2024-12-31$28.0Kn/a
Foghorn Therapeutics Inc. (FHTX)2025-12-31$50.0K-94.5%

Compare BHST, VRCA, ETST, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗